Jenny L. Wilkerson, PhD
Affiliations: | 2017- | Pharmacodynamics | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
pain, cannabinoids, neuroinflammationGoogle:
"Jenny Wilkerson"Mean distance: 15.96 (cluster 58) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentor| Erin D. Milligan | grad student | 2007-2012 | Univ. of New Mexico | |
| (Cannabinoid 2 receptor (CB2R) agonists modulate neuropathic pain and cytokine expression.) | ||||
| Aron H. Lichtman | post-doc | 2013-2017 | VCU | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wilkerson JL, Alberti LB, Thakur GA, et al. (2022) Peripherally administered cannabinoid receptor 2 (CBR) agonists lose anti-allodynic effects in TRPV1 knockout mice, while intrathecal administration leads to anti-allodynia and reduced GFAP, CCL2 and TRPV1 expression in the dorsal spinal cord and DRG. Brain Research. 1774: 147721 |
| Bilbrey JA, Ortiz YT, Felix JS, et al. (2021) Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement. Psychopharmacology |
| Wilkerson JL, Felix JS, Bilbrey JA, et al. (2021) Characterization of a mouse neuropathic pain model caused by the highly active antiviral therapy (HAART) Stavudine. Pharmacological Reports : Pr |
| Wilkerson JL, Alberti LB, Kerwin AA, et al. (2020) Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain. Brain and Behavior. e01850 |
| Wilkerson JL, Jiang J, Felix JS, et al. (2020) Alterations in mouse spinal cord and sciatic nerve microRNAs after the chronic constriction injury (CCI) model of neuropathic pain. Neuroscience Letters. 135029 |
| Sim-Selley LJ, Wilkerson JL, Burston JJ, et al. (2018) Differential Tolerance to FTY720-induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of S1P Receptor Adaptation. The Journal of Pharmacology and Experimental Therapeutics |
| Curry Z, Wilkerson J, Bagdas D, et al. (2018) Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy. The Journal of Pharmacology and Experimental Therapeutics |
| Wilkerson JL, Curry ZA, Kinlow PD, et al. (2018) Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice. Pain |
| Wilkerson JL, Donvito G, Grim TW, et al. (2017) Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model. The Journal of Pharmacology and Experimental Therapeutics |
| Donvito G, Nass SR, Wilkerson JL, et al. (2017) The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |